| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430808A1 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 06/27/2002 | CA2430782A1 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | CA2397990A1 Propofol formulation with enhanced microbial inhibition |
| 06/26/2002 | EP1216986A2 Novel delta dicarbonyl compounds and methods for using same |
| 06/26/2002 | EP1216708A1 A disinfectant for teats of animals, and a method for improving microorganism-environment harmful for animals |
| 06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216256A1 Macrolide antibiotics and treatment of pasteurellosis |
| 06/26/2002 | EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 06/26/2002 | EP1216241A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 06/26/2002 | EP1216055A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 06/26/2002 | EP1216054A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 06/26/2002 | EP1216053A2 Influenza vaccine |
| 06/26/2002 | EP1216044A1 Compositions having improved stability |
| 06/26/2002 | EP1216043A1 Retard form containing alpha-lipoic acid (derivatives) |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1185948A4 Method for screening and producing compound libraries |
| 06/26/2002 | EP1073414B1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 06/26/2002 | EP0778026B1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/26/2002 | EP0754050B1 Anti gram positive bacterial methods and materials |
| 06/26/2002 | EP0692963B1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0640077B1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials |
| 06/26/2002 | CN1355812A Pseudomycin analogs |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355798A 苯并咪唑化合物结晶 Benzimidazole compound crystallized |
| 06/26/2002 | CN1355789A Indigoid bisindole derivatives |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355708A HCV combination therapy containing ribavirin in association with antioxidants |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355699A Antifungal compositions |
| 06/26/2002 | CN1355697A IL-8 receptor antagonists |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355253A Humanized genetically engineered neutralizing antibody of rabies virus |
| 06/26/2002 | CN1355171A Extracting process and usage of general aralic chinensis saponin |
| 06/26/2002 | CN1355045A 'Shiyoushaxing' ointment for treating pointed condyloma and its preparing process |
| 06/26/2002 | CN1355043A Medicine 'Luolixiao' for treating scrofula |
| 06/26/2002 | CN1355040A Exterior-applied medicine for treating beriberi and tinea pedis and its preparing process |
| 06/26/2002 | CN1355026A Chinese medicine for treating tuberculosis |
| 06/26/2002 | CN1086588C Pseudomonas active protein and method for producing same |
| 06/26/2002 | CN1086579C Oral formulations of antifungal |
| 06/25/2002 | US6410729 Substituted pyrimidine compounds and methods of use |
| 06/25/2002 | US6410728 Oxazolidinone chemotherapeutic agents |
| 06/25/2002 | US6410726 Useful in treating and suppressing human cytomegalovirus |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410599 Mixture of benzalkonium chloride, water and isopropanol |
| 06/25/2002 | US6410594 Viricides |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410575 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, hiv and kaposi sarcoma, as viricides and anticarcinogenic agents |
| 06/25/2002 | US6410546 Aids therapy |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410534 Anticancer agents |
| 06/25/2002 | US6410531 For therapy of hepatitis c virus (hcv) infection |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410525 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410222 Immuniizng chicken eggs |
| 06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
| 06/25/2002 | US6410059 Pharmaceutical composition containing cow urine distillate and an antibiotic |
| 06/25/2002 | US6410040 Dissolving poly(2-propenal, 2-propenoic acid) in aqueous base, adding compound containing one or more hydrophobic groups, acidifying solution, whereby interaction between compound and polymer prevents precipitation over broad ph range |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/25/2002 | US6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 06/25/2002 | US6410021 Vaccines of pasteurellaceae mutants and vaccination method |
| 06/25/2002 | US6410016 Method for administering viable microorganism composition for poultry |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | US6409508 Use of ozone for the treatment of dental caries |
| 06/25/2002 | CA2227994C Carbapenem antibiotic, composition and method of preparation |
| 06/25/2002 | CA2217952C A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 06/25/2002 | CA2213609C New compounds to modulate hormone receptors, compositions containing them, and their therapeutic use |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2099586C Drug material suitable for micronisation |
| 06/25/2002 | CA2045546C Treatment of pulmonary dysfunction and ventilator dependency with growth hormone |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/21/2002 | CA2364841A1 A disinfectant for teats of animals, and a method for improving microorganism-environment harmful for animals |
| 06/21/2002 | CA2363758A1 Novel delta dicarbonyl compounds and methods for using same |
| 06/20/2002 | WO2002048397A2 Regulation of human adenylate cyclase, type vii |
| 06/20/2002 | WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048184A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |